Weber R, Bryan R T, Juranek D D
Parasitic Diseases Branch, Centers for Disease Control, Atlanta, Georgia 30333.
J Clin Microbiol. 1992 Nov;30(11):2869-73. doi: 10.1128/jcm.30.11.2869-2873.1992.
Epidemiologic and laboratory data suggest that coprodiagnostic methods may fail to detect Cryptosporidium oocysts in stool specimens of infected patients. To improve the efficacy of stool concentration procedures, we modified different steps of the Formalin-ethyl acetate (FEA) stool concentration technique and evaluated these modifications by examining stool samples seeded with known numbers of Cryptosporidium oocysts. Because these modifications failed to improve oocyst detection, we developed a new stool concentration technique that includes FEA sedimentation followed by layering and flotation over hypertonic sodium chloride solution to separate parasites from stool debris. Compared with the standard FEA procedure, this technique improved Cryptosporidium oocyst detection. The sensitivities of the two concentration techniques were similar for diarrheal (watery) stool specimens (100% of watery stool specimens seeded with 5,000 oocysts per g of stool were identified as positive by the new technique, compared with 90% of stools processed by the standard FEA technique). However, the most significant improvement in diagnosis occurred with formed stool specimens that were not fatty; 70 to 90% of formed stool specimens seeded with 5,000 oocysts were identified as positive by the new technique, compared with 0% of specimens processed by the standard FEA technique. One hundred percent of formed specimens seeded with 10,000 oocysts were correctly diagnosed by using the new technique, while 0 to 60% of specimens processed by the standard FEA technique were found positive. Similarly, only 50 to 90% of stool specimens seeded with 50,000 oocysts were identified as positive by using the standard FEA technique, compared with a 100% positive rate by the new technique. The new stool concentration procedure provides enhanced detection of Cryptosporidium oocysts in all stool samples.
流行病学和实验室数据表明,粪便诊断方法可能无法检测出感染患者粪便标本中的隐孢子虫卵囊。为提高粪便浓缩程序的效能,我们对福尔马林-乙酸乙酯(FEA)粪便浓缩技术的不同步骤进行了改进,并通过检测接种已知数量隐孢子虫卵囊的粪便样本对这些改进进行了评估。由于这些改进未能提高卵囊检测率,我们开发了一种新的粪便浓缩技术,该技术包括FEA沉淀,然后在高渗氯化钠溶液上分层和浮选,以将寄生虫与粪便残渣分离。与标准FEA程序相比,该技术提高了隐孢子虫卵囊的检测率。两种浓缩技术对腹泻(水样)粪便标本的敏感性相似(每克粪便接种5000个卵囊的水样粪便标本,新技术检测出阳性的比例为100%,而标准FEA技术处理的粪便标本为90%)。然而,在非脂肪性的成形粪便标本诊断方面有最显著改善;每克粪便接种5000个卵囊的成形粪便标本,新技术检测出阳性的比例为70%至90%,而标准FEA技术处理的标本为0%。使用新技术,每克粪便接种10000个卵囊的成形标本100%被正确诊断,而标准FEA技术处理的标本只有0%至60%被检测为阳性。同样,每克粪便接种50,000个卵囊的粪便标本,使用标准FEA技术只有50%至90%被检测为阳性,而新技术的阳性率为100%。新的粪便浓缩程序提高了所有粪便样本中隐孢子虫卵囊的检测率。